Andrew V. Schally, 97, Dies; Scientist Shared Nobel Glory With Rival
His two-decade quest to find elusive brain hormones became a race against Roger Guillemin, a onetime colleague and an eventual fellow prizewinner.
His two-decade quest to find elusive brain hormones became a race against Roger Guillemin, a onetime colleague and an eventual fellow prizewinner.
Eric Kim discusses the variation in prostate cancer genomic subtypes related to MRI PI-RADS scores and racial differences. He focused on the correlations between mpMRI…
Editas Medicine says its in vivo gene-editing therapy for hemoglobinopathies has best-in-class potential, but the company plans to out-license or partner that program. Editas is…
“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.
In this month’s episode, Senior Reporter Katie Adams explored some of the executive moves, exits and layoffs that recently occurred in the healthcare sector. She…
Representation of immigrant and Puerto Rican minority medical graduates has increased in the U.S.; however, they continue to experience frequent discrimination, according to study results…
LAS VEGAS—A year ago at HLTH, Highmark and Spring Health announced a partnership that aimed to boost access to behavioral health care. | LAS VEGAS—A…
LAS VEGAS—Actor, producer, director and entrepreneur Halle Berry wants to put a new spin on women’s longevity and menopause, a health condition that impacts millions…
The digital identity verification company seeks to be a mainstay for providers, insurers and patients.
Zachary Klaassen interviews Oliver Sartor about three significant prostate cancer trials presented at ESMO 2024. Dr. Sartor discusses the ARANOTE, PEACE-3, and the SPLASH trials.…
We’re only going to see more, not fewer, viral outbreaks due to several factors including:-The end of vaccination programs for diseases that have been eradic…